Análisis Argos
ASH
ASHSin veredicto2 señales de riesgo
Ashland Inc. · Basic Materials
US$ 67.01
precio al 2026-07-04
Valor justo Argos*
US$ 78
vs. su valor justo
▲+17%
Score Argos
45/100
Sin veredicto
LA RESPUESTA
Luce barata, pero tiene 2 señales de riesgo en sus números. Esperá: barato no siempre es ganga.
Recompensas
✓Cotiza 17% por debajo de su valor justo.
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
!Altman Z en zona roja (1.42)
!FCF negativo con deuda creciente
VALOR4/6FUTURO0/6PASADO1/6SALUD1/6DIVIDENDO5/6
El Iris de calidad
VALOR4/6FUTURO0/6PASADO1/6SALUD1/6DIVIDENDO5/6
ValorCotiza por debajo de su valor justo
FuturoIngresos estancados o cayendo
PasadoHistorial débil
SaludBalance frágil
DividendoDevuelve capital al accionista
Score Argos45de 100Sin veredicto
Ingresos▼14%
US$ 1.8 B
Margen operativo▲3442%
-42.5%
Flujo de caja libre▼100%
US$ 0 B
Deuda neta
US$ 1.4 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 3.1B
P/E—
EV/EBITDA—
FCF yield-0.1%
ROIC-23.7%
Margen operativo-42.5%
Crecim. ingresos-13.7%/año
Piotroski F6/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

gurufocus.com · 26 jun
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) acro
globenewswire.com · 10 jun
Ashland responds to investor presentation by Ancora Alternatives LLC
WILMINGTON, Del. , June 10, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today issued the following statement in response to the investor presentation released by Ancora Alternatives LLC: Ashland's Board of Directors and management team are committed to driving sustainable value creation for all shareholders.
globenewswire.com · 10 jun
Ashland responds to investor presentation by Ancora Alternatives LLC
WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today issued the following statement in response to the investor presentation released by Ancora Alternatives LLC: Ashland's Board of Directors and management team are committed to driving sustainable value creation for all shareholders.
zacks.com · 10 jun
New Strong Sell Stocks for June 10th
AOS, APOG and ASH have been added to the Zacks Rank #5 (Strong Sell) List on June 10, 2026.
businesswire.com · 9 jun
Ancora Releases Presentation Highlighting the Opportunity for a Value-Maximizing, Competitive Sale Process at Ashland Inc.
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora”) today released a presentation (available here) detailing what it believes is a near-term opportunity to realize the intrinsic value of Ashland Inc. (NYSE: ASH) (“Ashland” or the “Company”) through a sale of the Company. Ancora plans to engage in a constructive and open dialogue with Ashland to gauge the Board of Directors' willingness to evaluate the Company's standalone prospects versus a potent.
zacks.com · 8 jun
New Strong Sell Stocks for June 8th
AMTB, ACA and ASH have been added to the Zacks Rank #5 (Strong Sell) List on June 8, 2026.
seekingalpha.com · 5 jun
Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
zacks.com · 28 may
Why Is Ashland (ASH) Up 16.6% Since Last Earnings Report?
Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.